407 related articles for article (PubMed ID: 27702895)
1. Sustained antigen availability during germinal center initiation enhances antibody responses to vaccination.
Tam HH; Melo MB; Kang M; Pelet JM; Ruda VM; Foley MH; Hu JK; Kumari S; Crampton J; Baldeon AD; Sanders RW; Moore JP; Crotty S; Langer R; Anderson DG; Chakraborty AK; Irvine DJ
Proc Natl Acad Sci U S A; 2016 Oct; 113(43):E6639-E6648. PubMed ID: 27702895
[TBL] [Abstract][Full Text] [Related]
2. The role of follicular helper T cells and the germinal center in HIV-1 gp120 DNA prime and gp120 protein boost vaccination.
Hollister K; Chen Y; Wang S; Wu H; Mondal A; Clegg N; Lu S; Dent A
Hum Vaccin Immunother; 2014; 10(7):1985-92. PubMed ID: 25424808
[TBL] [Abstract][Full Text] [Related]
3. Divergent Primary Immune Responses Induced by Human Immunodeficiency Virus-1 gp120 and Hepatitis B Surface Antigen Determine Antibody Recall Responses.
Yuan L; Chen WJ; Wang JY; Li Y; Tian D; Wang MX; Yu HT; Xu YC; Li D; Zhuang M; Ling H
Virol Sin; 2018 Dec; 33(6):502-514. PubMed ID: 30569292
[TBL] [Abstract][Full Text] [Related]
4. Germinal center enhancement by extended antigen availability.
Cirelli KM; Crotty S
Curr Opin Immunol; 2017 Aug; 47():64-69. PubMed ID: 28738289
[TBL] [Abstract][Full Text] [Related]
5. Beraprost enhances production of antigen-specific IgG isotypes without modulating germinal center B cell generation and the affinity maturation.
Lee E; Kim J; Kim YM; Ha KS; Jeoung DI; Sin JI; Choe J
Int Immunopharmacol; 2013 Apr; 15(4):735-42. PubMed ID: 23499642
[TBL] [Abstract][Full Text] [Related]
6. Augmentation and suppression of immune responses to an HIV-1 DNA vaccine by plasmid cytokine/Ig administration.
Barouch DH; Santra S; Steenbeke TD; Zheng XX; Perry HC; Davies ME; Freed DC; Craiu A; Strom TB; Shiver JW; Letvin NL
J Immunol; 1998 Aug; 161(4):1875-82. PubMed ID: 9712056
[TBL] [Abstract][Full Text] [Related]
7. The adjuvant GLA-SE promotes human Tfh cell expansion and emergence of public TCRβ clonotypes.
Hill DL; Pierson W; Bolland DJ; Mkindi C; Carr EJ; Wang J; Houard S; Wingett SW; Audran R; Wallin EF; Jongo SA; Kamaka K; Zand M; Spertini F; Daubenberger C; Corcoran AE; Linterman MA
J Exp Med; 2019 Aug; 216(8):1857-1873. PubMed ID: 31175140
[TBL] [Abstract][Full Text] [Related]
8. Vaccine Adjuvants Differentially Affect Kinetics of Antibody and Germinal Center Responses.
Pedersen GK; Wørzner K; Andersen P; Christensen D
Front Immunol; 2020; 11():579761. PubMed ID: 33072125
[TBL] [Abstract][Full Text] [Related]
9. Oil-in-Water Emulsion MF59 Increases Germinal Center B Cell Differentiation and Persistence in Response to Vaccination.
Lofano G; Mancini F; Salvatore G; Cantisani R; Monaci E; Carrisi C; Tavarini S; Sammicheli C; Rossi Paccani S; Soldaini E; Laera D; Finco O; Nuti S; Rappuoli R; De Gregorio E; Bagnoli F; Bertholet S
J Immunol; 2015 Aug; 195(4):1617-27. PubMed ID: 26170383
[TBL] [Abstract][Full Text] [Related]
10. An alternative and effective HIV vaccination approach based on inhibition of antigen presentation attenuators in dendritic cells.
Song XT; Evel-Kabler K; Rollins L; Aldrich M; Gao F; Huang XF; Chen SY
PLoS Med; 2006 Jan; 3(1):e11. PubMed ID: 16381597
[TBL] [Abstract][Full Text] [Related]
11. Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in mice.
Bengtsson KL; Song H; Stertman L; Liu Y; Flyer DC; Massare MJ; Xu RH; Zhou B; Lu H; Kwilas SA; Hahn TJ; Kpamegan E; Hooper J; Carrion R; Glenn G; Smith G
Vaccine; 2016 Apr; 34(16):1927-35. PubMed ID: 26921779
[TBL] [Abstract][Full Text] [Related]
12. The utility of ISCOMATRIX adjuvant for dose reduction of antigen for vaccines requiring antibody responses.
Boyle J; Eastman D; Millar C; Camuglia S; Cox J; Pearse M; Good J; Drane D
Vaccine; 2007 Mar; 25(14):2541-4. PubMed ID: 17240491
[TBL] [Abstract][Full Text] [Related]
13. DNA vaccine molecular adjuvants SP-D-BAFF and SP-D-APRIL enhance anti-gp120 immune response and increase HIV-1 neutralizing antibody titers.
Gupta S; Clark ES; Termini JM; Boucher J; Kanagavelu S; LeBranche CC; Abraham S; Montefiori DC; Khan WN; Stone GW
J Virol; 2015 Apr; 89(8):4158-69. PubMed ID: 25631080
[TBL] [Abstract][Full Text] [Related]
14. Lymph node but not intradermal injection site macrophages are critical for germinal center formation and antibody responses to rabies vaccination.
Lytle AG; Shen S; McGettigan JP
J Virol; 2015 Mar; 89(5):2842-8. PubMed ID: 25540370
[TBL] [Abstract][Full Text] [Related]
15. Natural killer T cell and TLR9 agonists as mucosal adjuvants for sublingual vaccination with clade C HIV-1 envelope protein.
Singh S; Yang G; Byrareddy SN; Barry MA; Sastry KJ
Vaccine; 2014 Dec; 32(51):6934-6940. PubMed ID: 25444819
[TBL] [Abstract][Full Text] [Related]
16. DNA-MVA-protein vaccination of rhesus macaques induces HIV-specific immunity in mucosal-associated lymph nodes and functional antibodies.
Chege GK; Burgers WA; Müller TL; Gray CM; Shephard EG; Barnett SW; Ferrari G; Montefiori D; Williamson C; Williamson AL
Vaccine; 2017 Feb; 35(6):929-937. PubMed ID: 28069361
[TBL] [Abstract][Full Text] [Related]
17. E2 multimeric scaffold for vaccine formulation: immune response by intranasal delivery and transcriptome profile of E2-pulsed dendritic cells.
Trovato M; Maurano F; D'Apice L; Costa V; Sartorius R; Cuccaro F; McBurney SP; Krebs SJ; Prisco A; Ciccodicola A; Rossi M; Haigwood NL; De Berardinis P
BMC Microbiol; 2016 Jul; 16(1):152. PubMed ID: 27421762
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of immunogenicity of recombinant antigens by production of a cytokine-antigen fusion protein for vaccination.
McCormick AL; Thomas MS; Heath AW
Biochem Soc Trans; 1997 May; 25(2):297S. PubMed ID: 9191341
[No Abstract] [Full Text] [Related]
19. Comparative Systems Analyses Reveal Molecular Signatures of Clinically tested Vaccine Adjuvants.
Olafsdottir TA; Lindqvist M; Nookaew I; Andersen P; Maertzdorf J; Persson J; Christensen D; Zhang Y; Anderson J; Khoomrung S; Sen P; Agger EM; Coler R; Carter D; Meinke A; Rappuoli R; Kaufmann SH; Reed SG; Harandi AM
Sci Rep; 2016 Dec; 6():39097. PubMed ID: 27958370
[TBL] [Abstract][Full Text] [Related]
20. Capric acid and hydroxypropylmethylcellulose increase the immunogenicity of nasally administered peptide vaccines.
Nordone SK; Peacock JW; Kirwan SM; Staats HF
AIDS Res Hum Retroviruses; 2006 Jun; 22(6):558-68. PubMed ID: 16796531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
